Endocrinology Grand Rounds
3/19/2013 8:00 AM - 9:00 AM
Harold Hamm Diabetes Center, 2900
Diabetic Retinopathy - What's New?
Stephen Fransen, MD, Associate Professor, Ophthalmology, Dean McGee Eye Institute, Cofounder and Chief Medical Officer of Inoveon Corporation
Objectives: Upon completion of this activity, participants will be able to: Recognize the challenges facing evidence-based diabetic retinopathy care and critically assess their role as a provider in overcoming these challenges. To recognize what constitutes and adequate eye exam for diabetic retinopathy. To list the five levels of the International Clinical Diabetic Retinopathy Disease Severity Scale.
For more information contact:
Department of Medicine/Endocrinology and Diabetes
Number of CE Credits: 0